Marksans Pharma P/E Ratio

Current P/E Ratio
25.6
High Valuation
High - Growth expectations or overvalued

Marksans Pharma P/E ratio. Marksans Pharma (MARKSANS) P/E ratio is 25.6 (High), EPS (TTM) ₹9.22, current price ₹299.05 on NSE vs historical average P/E of 15.12 (85.7th percentile) — High - Growth expectations or overvalued. Check Marksans Pharma networth to track the company's total market size over time.

Current Valuation Metrics

P/E Ratio 25.6
Current Price ₹299.05
EPS (TTM) ₹9.22
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 15.12
Historical Range 3.55 - 38.27
Percentile 85.7%

Sector Context

Sector Average 52.3
Sector Median 29.6
Sector Rank #11 of 255
Sector Percentile 4.3%

Earnings Breakdown (TTM)

TTM EPS ₹12.03
Sept 2026 ₹3.12
Mar 2026 ₹3.27

MARKSANS P/E Ratio — Valuation Signal & Historical Context

Marksans Pharma P/E 25.6 vs historical average 15.12, range 3.55–38.27 — signal: Overvalued. Also explore MARKSANS stock price history to track price trends across different timeframes.

  • Stock appears overvalued with PE of 25.6, suggesting caution for new investments
  • Current PE is 69.3% above historical average
  • Trading at discount to sector average PE of 52.3

Marksans Pharma P/E Ratio Historical Trend

MARKSANS annual price-to-earnings ratio — 7 years, EPS and year-end price. Current P/E 25.6 vs historical average 15.12. For live price, revenue and the complete fundamental profile, see Marksans Pharma share price chart.

MARKSANS Historical P/E Ratio — EPS, Year-End Price & Valuation

Marksans Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 38.27 7.96 ₹304.65 NSE High
2024 19.76 8.13 ₹160.65 NSE Moderate
2023 8.21 7.17 ₹58.85 NSE Low
2022 11.82 5.23 ₹61.80 NSE Low
2021 10.6 5.75 ₹60.95 NSE Low
2020 3.55 4.83 ₹17.15 NSE Low
2019 13.62 2.07 ₹28.20 NSE Low

MARKSANS vs Healthcare Peers — P/E Ratio Comparison

Marksans Pharma P/E 25.6 vs Healthcare average 52.3, median 29.6 — range 2.0–733.0.

Sector Average
52.3
Sector Median
29.6
Lowest P/E
2.0
Highest P/E
733.0
Companies
255
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.0 ₹72 Low
Brooks Laboratories BROOKS 2.6 ₹206 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.3 ₹54 Low
Sun Pharma Advanced Rese… SPARC 4.1 ₹6,355 Low
Dipna Pharmachem DPL 4.5 ₹11 Low
JFL Life Sciences JFLLIFE 4.7 ₹82 Low
Royal Sense ROYAL 4.8 ₹34 Low
Star Imaging And Path Lab STARIMAGIN 5.3 ₹110 Low
Kabra Drugs KABRADG 6.3 ₹49 Low